Evaluation of Msh2, Mlh1, Brca1 and Fhit protein expression in T1 N0 M0 breast cancer

被引:0
|
作者
不详
机构
来源
BREAST | 2005年 / 14卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S15 / S16
页数:2
相关论文
共 50 条
  • [41] Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer
    Renkonen, E
    Zhang, YG
    Lohi, H
    Salovaara, R
    Abdel-Rahman, WM
    Nilbert, M
    Aittomäki, K
    Järvinen, HJ
    Mecklin, JP
    Lindblom, A
    Peltomäki, P
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3629 - 3637
  • [42] Correlation of MLH1 and MSH2 levels with clinicopathologic characteristics in colorectal cancer
    Guo, Ling
    Yu, Zhaohui
    Li, Qin
    Liang, Xiaohu
    Yang, Lindong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (02): : 1107 - 1116
  • [43] Clinical significance of MLH1/MSH2 for stage Ⅱ/Ⅲ sporadic colorectal cancer
    Shui-Ming Wang
    Bin Jiang
    Youping Deng
    Shu-Liang Huang
    Ming-Zhi Fang
    Yu Wang
    World Journal of Gastrointestinal Oncology, 2019, 11 (11) : 1065 - 1080
  • [44] Cancer risk in 348 French MSH2 or MLH1 gene carriers
    Parc, Y
    Boisson, C
    Thomas, G
    Olschwang, S
    JOURNAL OF MEDICAL GENETICS, 2003, 40 (03) : 208 - 213
  • [45] THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER
    FERGUSON, MK
    LITTLE, AG
    GOLOMB, HM
    HOFFMAN, PC
    DEMEESTER, TR
    BEVERIDGE, R
    SKINNER, DB
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03): : 344 - 349
  • [46] Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer
    Francesca Sanguedolce
    Antonella Cormio
    Paolo Massenio
    Maria C. Pedicillo
    Simona Cagiano
    Francesca Fortunato
    Beppe Calò
    Giuseppe Di Fino
    Giuseppe Carrieri
    Pantaleo Bufo
    Luigi Cormio
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 637 - 644
  • [47] Expression of E-Cadherin and α-Catenin in T1 N0 Laryngeal Cancer
    Carico, Elisabetta
    Radici, Marco
    Losito, Nunzia Simona
    Raffa, Salvatore
    Firrisi, Luca
    Fabiano, Alfredo
    Manola, Marco
    Vecchione, Aldo
    Giovagnoli, Maria Rosaria
    ANTICANCER RESEARCH, 2012, 32 (12) : 5245 - 5249
  • [48] Endocavitary contact radiation therapy for ultrasonographically staged T1 N0 and T2 N0 rectal cancer
    Christoforidis, D.
    McNally, M. P.
    Jarosek, S. L.
    Madoff, R. D.
    Finne, C. O.
    BRITISH JOURNAL OF SURGERY, 2009, 96 (04) : 430 - 436
  • [49] Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer
    Sanguedolce, Francesca
    Cormio, Antonella
    Massenio, Paolo
    Pedicillo, Maria C.
    Cagiano, Simona
    Fortunato, Francesca
    Calo, Beppe
    Di Fino, Giuseppe
    Carrieri, Giuseppe
    Bufo, Pantaleo
    Cormio, Luigi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (04) : 637 - 644
  • [50] Early prostate cancer (T1–2N0M0)
    Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Ave, Suite 1500, Miami
    FL
    33136, United States
    Intensity-Modulated Radiat. Therapy: Clinical Evid. and Techniques, (355-378):